Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk Medulloblastoma

NCT07291102 is registered in ClinicalTrials.gov with Nationwide Children's Hospital as lead sponsor.

NCT NCT07291102
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07291102 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk Medulloblastoma
Lead sponsor
Nationwide Children's Hospital
Phase
Phase 3
Overall status
Not yet recruiting
Start date
July 1, 2026
Completion date
October 31, 2038
Enrollment
96 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

medulloblastoma